|Molecular Weight of Agent||Both|
|Occupation|| Not specified|
|Outcome/Diagnosis||Occupational asthma and work aggravated asthma|
|Activity Intervention|| Removal from exposure (1-4 years)|
|Participation Rate||Limitation: no report of participation rate
18 subjects with occupational asthma and 10 with work-aggravated asthma|
|Intervention Effectiveness||For subjects with occupational asthma:
--Significant improvement in the respiratory symptoms and PC20.
--A large decrease in the dose of inhaled corticosteroids and in the need of short-acting beta2 agonists.
--A decrease in the sputum eosinophil counts (0.50%) compared with the time of their diagnosis (3.5%, p=0.1).
For subjects with work-aggravated asthma:
--Significant improvement in the respiratory symptoms.
--A decrease of their median neutrophil counts (49.5%)
compared with the time of their diagnosis (63.5%, p = 0.1)